Physician profile
Rishika Chugh
NPI 1881080257
$9,350.82
in general payments reported to CMS, 2019-2025
6 companies · $2,329 in 2025
The $2,329 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.32 · 2022: $6,816 · 2023: $128 · 2024: $30.40 · 2025: $2,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,329 · Food and Beverage: $128 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,328.75 |
| Food and Beverage | $128.24 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,902.11 | 2022-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $2,328.75 | 2025 | |
| Celgene Corporation | $1,016.11 | 2022-2023 | Zeposia |
| Boston Scientific Corporation | $47.32 | 2021 | |
| Pfizer INC. | $30.40 | 2024 | |
| Abbvie INC. | $26.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishika Chugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.